Personalized antiplatelet therapy after stroke or TIA
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Had a mild stroke (NIH Stroke Scale score 5 or less) or a TIA with moderate to high risk (ABCD₂ score 4 or more)
- Started taking clopidogrel and aspirin within 48 hours of symptoms starting
- Had a blood test measuring platelet function 5-20 hours after taking those drugs
- No bleeding conditions or recent major bleeding
- Not taking other blood thinners or having conditions like atrial fibrillation that require them
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests can predict if the antiplatelet drug clopidogrel (Plavix) will work well in people who have had a mild stroke or a mini-stroke (TIA). The goal is to help doctors choose the best treatment for each person.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This study tests whether adjusting blood-thinner medication based on a blood test can better prevent another stroke in people who recently had a minor stroke or a high-risk mini-stroke. It aims to find the safest and most effective dose for each patient.
This trial tests whether switching to a simpler antiplatelet medication (ticagrelor) after a mild stroke or high-risk TIA can prevent another stroke while reducing the risk of bleeding. It is for people who have not received clot-busting treatment or had a large stroke.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.